SAN DIEGO--(BUSINESS WIRE)--BioPharmCatalyst (BPC), a division of Scientist.com, today announced that members with an “Elite” and “Elite Plus” subscription now get full access to Trial Insights, which ...
HCW Biologics delivered Q1 2026 revenue of $6.54M, compared to only $5,065 in the same quarter last year, primarily from a $6.5M licensing agreement with Beijing Trimmune. The biotech firm achieved ...
For the last two years, Keytruda has reigned as the world’s top-selling drug—a distinction under threat with key patent protections expiring in 2028. The FDA has approved a subcutaneous version of ...
To say global markets have been choppy in 2025 is an understatement. Unsurprisingly, biopharma remains one of the most dynamic sectors, driven by late-stage clinical developments, regulatory decisions ...
SAN DIEGO, Jan. 9, 2025 /PRNewswire-PRWeb/ -- BioPharmCatalyst, a trusted source for clinical and financial data on publicly traded biotech companies, has partnered with BYTE51, a leader in clinical ...
Bringing together over 8,000 industry leaders, emerging innovators and influential investors, the J.P. Morgan (JPM) Healthcare Conference is the most significant catalyst event for the healthcare ...
New AI chatbot delivers seamless and personalized support for BioPharmCatalyst subscribers. SAN DIEGO, Oct. 8, 2024 /PRNewswire-PRWeb/ -- BioPharmCatalyst, a division of Scientist.com and a leader in ...
BioPharmCatalyst is an online resource for stock market investors of publicly traded biotech and pharmaceutical companies listed on U.S. markets (NASDAQ and NYSE). A commonly used function of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results